Quarterly report pursuant to Section 13 or 15(d)

OPTIONS AND WARRANTS (Tables)

v3.3.1.900
OPTIONS AND WARRANTS (Tables)
9 Months Ended
Dec. 31, 2015
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
                Weighted-  
          Weighted-     Average  
          Average     Remaining  
    Number of     Exercise     Contractual  
    Shares     Price     Term (years)  
Outstanding at March 31, 2014   120,000   $ 30.50     8.5  
Granted   347,040   $ 7.00     8.9  
Exercised   (3,640 ) $ 0.50     9.2  
Expired/Forfeited   (120,000 ) $   -     8.2  
Outstanding at March 31, 2015   343,400   $ 7.00     8.2  
Granted   -     -     -  
Exercised   -     -     -  
Expired/Forfeited   -   $   -     -  
Outstanding at December 31, 2015   343,400     7.00     8.2  
Exercisable at December 31, 2015   343,400     7.00     8.2  
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]
          Weighted-  
    Number     Average  
    of Warrants     Exercise Price  
Outstanding at March 31, 2014   166,208   $ 26.00  
   Granted   584,985     6.50  
   Exercised   (290,585 )   (15.50 )
   Cancelled   -     (15.50 )
Outstanding at March 31, 2015   460,608     7.00  
   Granted   358,057     10.27  
   Exercised   (254,763 )   8.00  
   Cancelled or Expired   (75,786 )   6.00  
Outstanding at December 31, 2015   488,116     9.62  
Warrants exercisable at December 31, 2015   488,116   $ 9.62  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
  STOCK WARRANTS OUTSTANDING AND
  EXERCISABLE
    Weighted-
    Average
  Number of Remaining
  Warrants Contractual
Exercise Price Outstanding Life in Years
$5.00 428,629 2.02
$6.25 6,667 3.05
$9.375 19,067 3.55
$27.50 2,326 2.07
Schedule of Share-based Payment Award, Warrants, Valuation Assumptions [Table Text Block]
Market value of stock on purchase date $ 3.75     to   $ 7.10  
Risk-free interest rate   . 26%     to     1.42%  
Dividend yield         0.00%        
Volatility factor   116%     to     161%  
Weighted average expected life (years)         2